The Loesgen Lab uses a variety of state-of-the-art techniques to identify and develop drug leads from the metabolic products of microbial organisms, with a special emphasis on endophytic fungi and rare actinomycetes. Our research program currently focuses on the discovery of new anticancer, antimicrobial, and antiviral compounds from microbial sources.

Our multidisciplinary approach to biomedical research brings together students and researchers from diverse backgrounds, including pharmaceutical sciences, chemistry, biochemistry, molecular biology, and microbiology.